Avinger (NASDAQ:AVGR) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a research note released on Wednesday. The firm issued a hold rating on the medical device company’s stock.

Separately, HC Wainwright restated a buy rating and set a $5.00 price objective on shares of Avinger in a research report on Thursday, March 21st.

Avinger Trading Up 0.3 %

Shares of AVGR stock opened at $3.70 on Wednesday. The stock has a market cap of $5.87 million, a P/E ratio of -0.14 and a beta of 1.26. The stock has a 50 day simple moving average of $3.42 and a 200 day simple moving average of $3.33. Avinger has a 1 year low of $2.50 and a 1 year high of $18.00.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings results on Wednesday, March 20th. The medical device company reported ($3.93) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by ($4.57). The company had revenue of $1.91 million during the quarter, compared to analyst estimates of $2.52 million. Analysts forecast that Avinger will post -2.08 EPS for the current year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.